PORTON PHARMA SOLUTIONS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.41 CNY | -3.12% |
|
+3.57% | -30.78% |
ETFs positioned on Porton Pharma Solutions Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.39% | 2 M€ | -12.22% | - | |
| 0.21% | 12 M€ | -16.71% | - | |
| 0.00% | 32 M€ | +7.24% | - | |
| 0.00% | 34 M€ | +3.63% | - | |
| 0.00% | 15 M€ | +15.41% |
Porton Pharma Solutions Ltd., formerly Porton Fine Chemicals Ltd., is a China-based company principally engaged in the provision of customized pharmaceutical research and production services. The Company is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The Company operates its businesses in Europe, North America, Asia and China, among others.
Sector
Pharmaceuticals
Calendar
20/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.41
CNY
Average target price
26.65
CNY
Spread / Average Target
+53.07%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.78% | 131.57Cr | |
| +30.38% | 68TCr | |
| +29.92% | 57TCr | |
| -4.36% | 36TCr | |
| +19.30% | 33TCr | |
| +3.73% | 28TCr | |
| +15.94% | 24TCr | |
| +9.34% | 21TCr | |
| -7.36% | 20TCr | |
| +7.68% | 17TCr |
- Stock Market
- Equities
- 300363 Stock
- Funds and ETFs Porton Pharma Solutions Ltd.